{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:33:14Z","timestamp":1750941194191,"version":"3.40.5"},"reference-count":32,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>In conjunction with radio-chemotherapy, pulmonary resection is recommended for early-stage nonsmall- cell lung carcinoma but not for advanced-stage NSCLC patients having high-grade metastatic lesions. In these cases, the rapid Arc-Stereotactic body radiotherapy (Ra-SBRT) technique offers a therapeutic advantage by delivering focal irradiation to metastatic lung lesions and reduces the bystander toxicity to normal tissues. We have previously demonstrated that Ra-SBRT ablates metastatic lesions and induces tumor immune rejection of metastatic tumors by promoting in situ programming of M2 TAM towards M1-TAM and infiltration of Siglec-8+ Eosinophils. Most interestingly, Ra SBRT has very low abscopal impact and spares normal tissues, which are the significant limitations with conventional radiotherapy. In view of this and the immune adjuvant potential of Ra SBRT, it promotes normalization of aberrant vasculature and inhibits the metastatic potential of NSCLC lesions. In view of this, we here propose that Ra-SBRT indeed represents an immunogenic approach for the effective management of advanced-stage NSCLC.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871520621666210322105641","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T10:58:29Z","timestamp":1616497109000},"page":"202-205","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rapid Arc-SBRT: Non-Invasive Immune Adjuvant for Advanced Stage Non-Small Cell Lung Carcinoma"],"prefix":"10.2174","volume":"22","author":[{"given":"Arun","family":"Chairmadurai","sequence":"first","affiliation":[{"name":"Jaypee Hospital, Sector -128, NOIDA, UP, India | Amity Centre for Radiation Biology, Amity University, Uttar Pradesh, Sector - 125, NOIDA, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep K.","family":"Jain","sequence":"additional","affiliation":[{"name":"Jaypee Hospital, Sector -128, NOIDA, UP, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aklank","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Zoology, Central University of Punjab, Bathinda, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5269-2481","authenticated-orcid":true,"given":"Hridayesh","family":"Prakash","sequence":"additional","affiliation":[{"name":"Amity Institute of Virology and Immunology, Amity University, Uttar Pradesh, Sector -125, NOIDA, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jama.2010.261","volume":"303","author":"Timmerman R.","year":"2010","unstructured":"Timmerman R.; Paulus R.; Galvin J.; Michalski J.; Straube W.; Bradley J.; Fakiris A.; Bezjak A.; Videtic G.; Johnstone D.; Fowler J.; Gore E.; Choy H.; Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010,303(11),1070-1076","journal-title":"JAMA"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","volume":"24","author":"Timmerman R.","year":"2006","unstructured":"Timmerman R.; McGarry R.; Yiannoutsos C.; Papiez L.; Tudor K.; DeLuca J.; Ewing M.; Abdulrahman R.; DesRosiers C.; Williams M.; Fletcher J.; Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006,24(30),4833-4839","journal-title":"J Clin Oncol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-717X-4-1","volume":"4","author":"Hurkmans C.W.","year":"2009","unstructured":"Hurkmans C.W.; Cuijpers J.P.; Lagerwaard F.J.; Widder J.; van der Heide U.A.; Schuring D.; Senan S.; Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol 2009,4,1","journal-title":"Radiat Oncol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12194-017-0431-4","volume":"10","author":"Chairmadurai A.","year":"2017","unstructured":"Chairmadurai A.; Goel H.C.; Jain S.K.; Kumar P.; Radiobiological analysis of stereotactic body radiation therapy for an evidence-based planning target volume of the lung using multiphase CT images obtained with a pneumatic abdominal compression apparatus: a case study. Radiological Phys Technol 2017,10(4),525-534","journal-title":"Radiological Phys Technol"},{"key":"ref=5","doi-asserted-by":"publisher","DOI":"10.4161\/onci.28133","volume":"3","author":"Golden E.B.","year":"2014","unstructured":"Golden E.B.; Formenti S.C.; Is tumor (R) ejection by the immune system the &#x201C;5th R&#x201D; of radiobiology? OncoImmunology 2014,3(1)","journal-title":"OncoImmunology"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","volume":"15","author":"Dewan M.Z.","year":"2009","unstructured":"Dewan M.Z.; Galloway A.E.; Kawashima N.; Dewyngaert J.K.; Babb J.S.; Formenti S.C.; Demaria S.; Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res 2009,15(17),5379-5388","journal-title":"Clin Cancer Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijrobp.2008.06.1939","volume":"74","author":"Guckenberger M.","year":"2009","unstructured":"Guckenberger M.; Wulf J.; Mueller G.; Krieger T.; Baier K.; Gabor M.; Richter A.; Wilbert J.; Flentje M.; Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation. Int J Radiat Oncol Biol Phys 2009,74(1),47-54","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1200\/JCO.2006.09.8178","volume":"25","author":"Senan S.","year":"2007","unstructured":"Senan S.; Haasbeek N.J.; Smit E.F.; Lagerwaard F.J.; Stereotactic radiotherapy for centrally located early-stage lung tumors. J Clin Oncol 2007,25(4),464","journal-title":"J Clin Oncol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1080\/09553002.2019.1623429","volume":"95","author":"Ko E.C.","year":"2019","unstructured":"Ko E.C.; Formenti S.C.; Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality. Int J Radiat Biol 2019,95(7),936-939","journal-title":"Int J Radiat Biol"},{"key":"ref=10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133212","volume":"20","author":"Jarosz-Biej M.","year":"2019","unstructured":"Jarosz-Biej M.; Smolarczyk R.; Cicho\u0144 T.; Ku\u0142ach N.; Tumor Microenvironment as A &#x201C;Game Changer&#x201D; in Cancer Radiotherapy. Int J Mol Sci 2019,20(13)","journal-title":"Int J Mol Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1158\/1078-0432.CCR-18-2581","volume":"25","author":"Wang Y.","year":"2019","unstructured":"Wang Y.; Liu Z.G.; Yuan H.; Deng W.; Li J.; Huang Y.; Kim B.Y.S.; Story M.D.; Jiang W.; The reciprocity between radiotherapy and cancer immunotherapy. Clin Cancer Res 2019,25(6),1709-1717","journal-title":"Clin Cancer Res"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12041047","volume":"12","author":"Asadzadeh Z.","year":"2020","unstructured":"Asadzadeh Z.; Safarzadeh E.; Safaei S.; Baradaran A.; Mohammadi A.; Hajiasgharzadeh K.; Derakhshani A.; Argentiero A.; Silvestris N.; Baradaran B.; Current approaches for combination therapy of cancer: The role of immunogenic cell death. Cancers (Basel) 2020,12(4)","journal-title":"Cancers (Basel)"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102762","volume":"12","author":"Zhao X.","year":"2020","unstructured":"Zhao X.; Shao C.; Radiotherapy-mediated immunomodulation and anti-tumor abscopal effect combining immune checkpoint blockade. Cancers (Basel) 2020,12(10)","journal-title":"Cancers (Basel)"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"6859","DOI":"10.2147\/OTT.S253772","volume":"13","author":"Liao Y.","year":"2020","unstructured":"Liao Y.; Liu S.; Fu S.; Wu J.; HMGB1 in radiotherapy: A two headed signal regulating tumor radiosensitivity and immunity. OncoTargets Ther 2020,13,6859-6871","journal-title":"OncoTargets Ther"},{"key":"ref=15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.568759","volume":"11","author":"Lee Y.H.","year":"2020","unstructured":"Lee Y.H.; Tai D.; Yip C.; Choo S.P.; Chew V.; Combinational immunotherapy for hepatocellular carcinoma: radiotherapy, immune checkpoint blockade and beyond. Front Immunol 2020,11","journal-title":"Front Immunol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1186\/s12885-020-07403-1","volume":"20","author":"Li L.","year":"2020","unstructured":"Li L.; Yue H.C.; Han Y.W.; Liu W.; Xiong L.G.; Zhang J.W.; Relationship between the invasion of lymphocytes and cytokines in the tumor microenvironment and the interval after single brachytherapy hypofractionated radiotherapy and conventional fractionation radiotherapy in non-small cell lung Cancer. BMC Cancer 2020,20(1),893","journal-title":"BMC Cancer"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrc3958","volume":"15","author":"Barker H.E.","year":"2015","unstructured":"Barker H.E.; Paget J.T.; Khan A.A.; Harrington K.J.; The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 2015,15(7),409-425","journal-title":"Nat Rev Cancer"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2018\/e557s","volume":"73","author":"Carvalho H.A.","year":"2018","unstructured":"Carvalho H.A.; Villar R.C.; Radiotherapy and immune response: the systemic effects of a local treatment. Clinics (S&#xE3;o Paulo) 2018,73(Suppl. 1)","journal-title":"Clinics (S&#xE3;o Paulo)"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ctrv.2005.03.004","volume":"31","author":"Kaminski J.M.","year":"2005","unstructured":"Kaminski J.M.; Shinohara E.; Summers J.B.; Niermann K.J.; Morimoto A.; Brousal J.; The controversial abscopal effect. Cancer Treat Rev 2005,31(3),159-172","journal-title":"Cancer Treat Rev"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fimmu.2015.00505","volume":"6","author":"Derer A.","year":"2015","unstructured":"Derer A.; Deloch L.; Rubner Y.; Fietkau R.; Frey B.; Gaipl U.S.; radio-immunotherapy-induced immunogenic cancer cells as basis for induction of systemic anti-tumor immune responses - pre-clinical evidence and ongoing clinical applications. Front Immunol 2015,6,505","journal-title":"Front Immunol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jnci\/djs629","volume":"105","author":"Formenti S.C.","year":"2013","unstructured":"Formenti S.C.; Demaria S.; Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 2013,105(4),256-265","journal-title":"J Natl Cancer Inst"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ccr.2013.09.014","volume":"24","author":"Klug F.","year":"2013","unstructured":"Klug F.; Prakash H.; Huber P.E.; Seibel T.; Bender N.; Halama N.; Pfirschke C.; Voss R.H.; Timke C.; Umansky L.; Klapproth K.; Sch&#xE4;kel K.; Garbi N.; J&#xE4;ger D.; Weitz J.; Schmitz-Winnenthal H.; H&#xE4;mmerling G.J.; Beckhove P.; Low-dose irradiation programs macrophage differentiation to an iNOS\/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell 2013,24(5),589-602","journal-title":"Cancer Cell"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/carcin\/bgw007","volume":"37","author":"Prakash H.","year":"2016","unstructured":"Prakash H.; Klug F.; Nadella V.; Mazumdar V.; Schmitz-Winnenthal H.; Umansky L.; Low doses of gamma irradiation potentially modifies immunosuppressive tumor microenvironment by retuning tumor-associated macrophages: lesson from insulinoma. Carcinogenesis 2016,37(3),301-313","journal-title":"Carcinogenesis"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/1078-0432.728.11.2","volume":"11","author":"Demaria S.","year":"2005","unstructured":"Demaria S.; Kawashima N.; Yang A.M.; Devitt M.L.; Babb J.S.; Allison J.P.; Formenti S.C.; Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clin Cancer Res 2005,11(2 Pt 1),728-734","journal-title":"Clin Cancer Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1158\/2326-6066.CIR-13-0115","volume":"1","author":"Golden E.B.","year":"2013","unstructured":"Golden E.B.; Demaria S.; Schiff P.B.; Chachoua A.; Formenti S.C.; An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. Cancer Immunol Res 2013,1(6),365-372","journal-title":"Cancer Immunol Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1163\/15685590260461066","volume":"32","author":"Arpaci F.","year":"2002","unstructured":"Arpaci F.; Dogru T.; Ozturk B.; Komurcu S.; Ozet A.; Yilmaz M.I.; Beyzadeoglu M.; Turan M.; Sengul A.; Yalcin A.; Changes in immunological recovery in patients who received post-transplant G-CSF or GM-CSF after autologous peripheral blood stem cell transplantation (PBSCT). Haematologia (Budap) 2002,32(3),253-264","journal-title":"Haematologia (Budap)"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1200\/JCO.2002.20.1.58","volume":"20","author":"de Gast G.C.","year":"2002","unstructured":"de Gast G.C.; Vyth-Dreese F.A.; Nooijen W.; van den Bogaard C.J.; Sein J.; Holtkamp M.M.; Linthorst G.A.; Baars J.W.; Schornagel J.H.; Rodenhuis S.; Reinfusion of autologous lymphocytes with granulocyte-macrophage colony-stimulating factor induces rapid recovery of CD4+ and CD8+ T cells after high-dose chemotherapy for metastatic breast cancer. J Clin Oncol 2002,20(1),58-64","journal-title":"J Clin Oncol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/ijms.21433","volume":"15","author":"Lachmann G.","year":"2018","unstructured":"Lachmann G.; von Haefen C.; Kurth J.; Yuerek F.; Spies C.; Innate immunity recovers earlier than acquired immunity during severe postoperative immunosuppression. Int J Med Sci 2018,15(1),1-9","journal-title":"Int J Med Sci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/cas.14199","volume":"111","author":"Khandelwal A.","year":"2020","unstructured":"Khandelwal A.; Seam R.K.; Gupta M.; Rana M.K.; Prakash H.; Vasquez K.M.; Jain A.; Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer. Cancer Sci 2020,111(3),826-839","journal-title":"Cancer Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.biochi.2018.10.006","volume":"156","author":"Malhotra A.","year":"2019","unstructured":"Malhotra A.; Sharma U.; Puhan S.; Chandra Bandari N.; Kharb A.; Arifa P.P.; Thakur L.; Prakash H.; Vasquez K.M.; Jain A.; Stabilization of miRNAs in esophageal cancer contributes to radioresistance and limits efficacy of therapy. Biochimie 2019,156,148-157","journal-title":"Biochimie"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/1878-0261.12606","volume":"14","author":"Tian X.","year":"2020","unstructured":"Tian X.; Wu Y.; Yang Y.; Wang J.; Niu M.; Gao S.; Qin T.; Bao D.; Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt\/&#x3B2;-catenin signaling. Mol Oncol 2020,14(2),462-483","journal-title":"Mol Oncol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10142-019-00696-x","volume":"20","author":"Li Z.","year":"2020","unstructured":"Li Z.; Feng C.; Guo J.; Hu X.; Xie D.; GNAS-AS1\/miR-4319\/NECAB3 axis promotes migration and invasion of non-small cell lung cancer cells by altering macrophage polarization. Funct. Integr. Genomics, 2020,20(1),17-28"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/192377","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/192377\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/192377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T06:09:55Z","timestamp":1671689395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/192377\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520621666210322105641","relation":{},"ISSN":["1871-5206"],"issn-type":[{"type":"print","value":"1871-5206"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-09-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}